We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Lokelma (sodium zirconium cyclosilicate) for treating high potassium levels (hyperkalemia). Understand its dosage, how to take it, and important precautions for patients in India.

High potassium levels, a condition known as hyperkalemia, can pose significant health risks. Fortunately, medications like Lokelma (sodium zirconium cyclosilicate) are available to help manage this condition. This blog post provides a comprehensive guide to understanding Lokelma, its dosage, how to take it, and important considerations for patients in India.
Lokelma is a prescription medication used to treat hyperkalemia in adults. It works by binding to potassium in the gastrointestinal tract, preventing its absorption into the bloodstream and promoting its excretion from the body. This helps to lower and maintain healthy potassium levels.
Lokelma is available in two strengths:
It comes as a powder in individual foil packets, which needs to be mixed with water before consumption.
The dosage of Lokelma is tailored to individual needs and is determined by your doctor based on your potassium levels and overall health. Here are the general dosage guidelines:
The typical starting dosage for treating hyperkalemia is 10 g taken three times per day for the first 48 hours (2 days). This intensive phase aims to rapidly reduce high potassium levels.
After the initial 48-hour treatment, if continued therapy is needed, your doctor will likely lower your dosage. The goal is to maintain potassium levels within the normal range. Common maintenance dosages include:
Your doctor will monitor your blood potassium levels regularly and adjust your dosage as needed. Adjustments are typically made weekly, often in increments of 5 g, until the desired potassium level is achieved and maintained.
If you have chronic kidney disease and are undergoing hemodialysis, your doctor will adjust your Lokelma dosage. You will typically take Lokelma only on days when you do not have dialysis.
Lokelma is administered orally. Follow these steps for proper administration:
Lokelma can be taken with or without food.
If you miss a dose of Lokelma, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
If you suspect you have taken too much Lokelma, contact your doctor immediately. In India, you can also reach out to the National Poisons Information Centre or seek emergency medical help. If you experience severe symptoms, call emergency services (like 112 or your local emergency number) or go to the nearest hospital emergency room.
It is essential to consult your doctor in the following situations:
Store Lokelma at room temperature as recommended by your doctor or pharmacist. For information on proper disposal of unused medication, consult your healthcare provider.
Some pharmacies offer medication labels with features like scannable QR codes that can convert text to audio, aiding individuals with visual impairments. Inquire with your pharmacist about available accessibility options.
Lokelma is an effective medication for managing hyperkalemia. Understanding its dosage, administration, and potential interactions is key to successful treatment. Always follow your doctor's advice and communicate any concerns to ensure the best possible health outcomes.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026

Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026